What Bryan Johnson Says About Longevity
3 episodes featuring Bryan Johnson on longevity
Key Insights on Longevity
Visual phenotypes drive longevity acceptance - 'nobody cares about biomarkers, they just wanted to look at skin and face' - Johnson
- Proposed $1 million longevity prize for visual interventions that achieve legal implementation in risk-tolerant jurisdictions
- Longitudinal diagnostic network state could precede longevity treatments, providing time-series data for 100-1000 characterized individuals
- GLP-1 drugs represent the first mainstream longevity therapy with visible effects beyond weight loss, including cognitive benefits